1. Managing immune checkpoint inhibitor-associated gastritis: Insights and strategies.
- Author
-
Yu LL, He ZL, and Qian XL
- Subjects
- Humans, Neoplasms drug therapy, Neoplasms immunology, Immune Checkpoint Inhibitors adverse effects, Gastritis chemically induced, Gastritis immunology, Gastritis diagnosis, Gastritis drug therapy
- Abstract
Immune checkpoint inhibitors (ICIs) are widely used due to their effectiveness in treating various tumors. Immune-related adverse events (irAEs) are defined as adverse effects resulting from ICI treatment. Gastrointestinal irAEs are a common type of irAEs characterized by intestinal side effects, such as diarrhea and colitis, which may lead to the discontinuation of ICIs., Competing Interests: Conflict-of-interest statement: The authors declare no conflicts of interest., (©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF